The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Inhibiting the C5–C5a receptor axis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947
Atypical Hemolytic–Uremic Syndrome
Noris, M., & Remuzzi, G. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0902814 · Cited by 1,338
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
Hillmen, P., Young, N. S., Schubert, J., Brodsky, R. A., Socié, G., Muus, P., Röth, A., Szer, J., Elebute, M. O., Nakamura, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061648 · Cited by 1,303
Complement regulators and inhibitory proteins
Zipfel, P. F., & Skerka, C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2620 · Cited by 1,264
Petersen, M. (2003) · Phytochemistry · doi:10.1016/s0031-9422(02)00513-7 · Cited by 1,234
ROLE OF C5A IN INFLAMMATORY RESPONSES
Guo, R.-F., & Ward, P. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115835 · Cited by 1,021
Generation of C5a in the absence of C3: a new complement activation pathway
Huber-Lang, M., Sarma, J. V., Zetoune, F. S., Rittirsch, D., Neff, T. A., McGuire, S. R., Lambris, J. D., Warner, R. L., Flierl, M. A., Hoesel, L. M., et al. (2006) · Nature Medicine · doi:10.1038/nm1419 · Cited by 975
TRAF1–C5 as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study
Plenge, R. M., Seielstad, M., Padyukov, L., Lee, A. T., Remmers, E. F., Ding, B., Liew, A., Khalili, H., Chandrasekaran, A., Davies, L. R. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073491 · Cited by 823
Modulation of the antitumor immune response by complement
Markiewski, M. M., DeAngelis, R. A., Benencia, F., Ricklin-Lichtsteiner, S. K., Koutoulaki, A., Gerard, C., Coukos, G., & Lambris, J. D. (2008) · Nature Immunology · doi:10.1038/ni.1655 · Cited by 778
Molecular Intercommunication between the Complement and Coagulation Systems
Amara, U., Flierl, M. A., Rittirsch, D., Klos, A., Chen, H., Acker, B., Brückner, U. B., Nilsson, B., Gebhard, F., Lambris, J. D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903678 · Cited by 720
Arthritis Critically Dependent on Innate Immune System Players
Ji, H., Ohmura, K., Mahmood, U., Lee, D. M., Hofhuis, F. M. A., Boackle, S. A., Takahashi, K., Holers, V. M., Walport, M., Gerard, C., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00275-3 · Cited by 693
Beck, K. D., Nguyen, H. X., Galvan, M. D., Salazar, D. L., Woodruff, T. M., & Anderson, A. J. (2010) · Brain · doi:10.1093/brain/awp322 · Cited by 646
Self-citationHillmen, P., Hall, C., Marsh, J. C. W., Elebute, M., Bombara, M. P., Petro, B. E., Cullen, M. J., Richards, S. J., Rollins, S. A., Mojcik, C. F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031688 · Cited by 635
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P., Spruce, L., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318817 · Cited by 594
Hillmen, P., Muus, P., Dührsen, U., Risitano, A. M., Schubert, J., Luzzatto, L., Schrezenmeier, H., Szer, J., Brodsky, R. A., Hill, A., et al. (2007) · Blood · doi:10.1182/blood-2007-06-095646 · Cited by 579
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P., Spruce, L., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18817 · Cited by 575
Chemotaxis Inhibitory Protein of Staphylococcus aureus, a Bacterial Antiinflammatory Agent
de Haas, C. J. C., Veldkamp, K. E., Peschel, A., Weerkamp, F., Van Wamel, W. J. B., Heezius, E. C. J. M., Poppelier, M. J. J. G., Van Kessel, K. P. M., & van Strijp, J. A. G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031636 · Cited by 471
The proinflammatory mediators C3a and C5a are essential for liver regeneration
Strey, C. W., Markiewski, M., Mastellos, D., Tudoran, R., Spruce, L. A., Greenbaum, L. E., & Lambris, J. D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030374 · Cited by 436
Function, structure and therapeutic potential of complement C5a receptors
Monk, P. N., Scola, A., Madala, P., & Fairlie, D. P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707332 · Cited by 404
Functional roles for C5a receptors in sepsis
Rittirsch, D., Flierl, M. A., Nadeau, B. A., Day, D. E., Huber-Lang, M., Mackay, C. R., Zetoune, F. S., Gerard, N. P., Cianflone, K., Köhl, J., et al. (2008) · Nature Medicine · doi:10.1038/nm1753 · Cited by 386
Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv
Thomas, T. C., Rollins, S. A., Rother, R. P., Giannoni, M. A., Hartman, S. L., Elliott, E. A., Nye, S. H., Matis, L. A., Squinto, S. P., & Evans, M. J. (1996) · Molecular Immunology · doi:10.1016/s0161-5890(96)00078-8 · Cited by 363
Fischetti, F., Durigutto, P., Pellis, V., Debeus, A., Macor, P., Bulla, R., Bossi, F., Ziller, F., Sblattero, D., Meroni, P., et al. (2005) · Blood · doi:10.1182/blood-2005-03-1319 · Cited by 351
Self-citationWang, Y., Hu, Q., Madri, J. A., Rollins, S. A., Chodera, A., & Matis, L. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8563 · Cited by 336
Lajoie, S., Lewkowich, I. P., Suzuki, Y., Clark, J. R., Sproles, A. A., Dienger, K., Budelsky, A. L., & Wills-Karp, M. (2010) · Nature Immunology · doi:10.1038/ni.1926 · Cited by 329
Granger, C. B., Mahaffey, K. W., Weaver, W. D., Theroux, P., Hochman, J. S., Filloon, T. G., Rollins, S., Todaro, T. G., Nicolau, J. C., Ruzyllo, W., et al. (2003) · Circulation · doi:10.1161/01.cir.0000087447.12918.85 · Cited by 323
Shushakova, N., Skokowa, J., Schulman, J., Baumann, U., Zwirner, J., Schmidt, R. E., & Gessner, J. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16577 · Cited by 284
C5a Negatively Regulates Toll-like Receptor 4-Induced Immune Responses
Hawlisch, H., Belkaid, Y., Baelder, R., Hildeman, D., Gerard, C., & Köhl, J. (2005) · Immunity · doi:10.1016/j.immuni.2005.02.006 · Cited by 276
Heinen, S., Hartmann, A., Lauer, N., Wiehl, U., Dahse, H.-M., Schirmer, S., Gropp, K., Enghardt, T., Wallich, R., Hälbich, S., et al. (2009) · Blood · doi:10.1182/blood-2009-02-205641 · Cited by 272
Fonseca, M. I., Ager, R. R., Chu, S.-H., Yazan, O., Sanderson, S. D., LaFerla, F. M., Taylor, S. M., Woodruff, T. M., & Tenner, A. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901005 · Cited by 268
Self-citationTrouw, L. A., Haisma, E. M., Levarht, E. W. N., van der Woude, D., Ioan‐Facsinay, A., Daha, M. R., Huizinga, T. W. J., & Toes, R. E. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24622 · Cited by 264
Complement in human diseases: Lessons from complement deficiencies
Botto, M., Kirschfink, M., Macor, P., Pickering, M. C., Würzner, R., & Tedesco, F. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.029 · Cited by 262
Self-citationC5L2, a Nonsignaling C5A Binding Protein
Okinaga, S., Slattery, D., Humbles, A., Zsengeller, Z., Morteau, O., Kinrade, M. B., Brodbeck, R. M., Krause, J. E., Choe, H.-R., Gerard, N. P., et al. (2003) · Biochemistry · doi:10.1021/bi034489v · Cited by 261
Ratajczak, M. Z., Lee, H., Wysoczynski, M., Wan, W., Marlicz, W., Laughlin, M. J., Kucia, M., Janowska-Wieczorek, A., & Ratajczak, J. (2010) · Leukemia · doi:10.1038/leu.2010.53 · Cited by 253
The C5a Receptor (C5aR) C5L2 Is a Modulator of C5aR-mediated Signal Transduction
Bamberg, C. E., Mackay, C. R., Lee, H., Zahra, D., Jackson, J., Lim, Y. S., Whitfeld, P. L., Craig, S., Corsini, E., Lu, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.092106 · Cited by 249
Low-Molecular-Weight Peptidic and Cyclic Antagonists of the Receptor for the Complement Factor C5a
Finch, A. M., Wong, A. K., Paczkowski, N. J., Wadi, S. K., Craik, D. J., Fairlie, D. P., & Taylor, S. M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9806594 · Cited by 246
Cain, S. A., & Monk, P. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100714200 · Cited by 245
C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a
Chen, N.-J., Mirtsos, C., Suh, D., Lu, Y.-C., Lin, W.-J., McKerlie, C., Lee, T., Baribault, H., Tian, H., & Yeh, W.-C. (2007) · Nature · doi:10.1038/nature05559 · Cited by 243
Miyata, T., Yamada, N., Iida, Y., Nishimura, J., Takeda, J., Kitani, T., & Kinoshita, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300404 · Cited by 236
Langley, R., Wines, B., Willoughby, N., Basu, I., Proft, T., & Fraser, J. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2926 · Cited by 236
Postma, B., Poppelier, M. J., van Galen, J. C., Prossnitz, E. R., van Strijp, J. A. G., de Haas, C. J. C., & van Kessel, K. P. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6994 · Cited by 235
Staphylococcal complement evasion by various convertase-blocking molecules
Jongerius, I., Köhl, J., Pandey, M. K., Ruyken, M., van Kessel, K. P. M., van Strijp, J. A. G., & Rooijakkers, S. H. M. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070818 · Cited by 233
A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma
Kohl, J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26582 · Cited by 217
Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria
Hill, A., Hillmen, P., Richards, S. J., Elebute, D., Marsh, J. C., Chan, J., Mojcik, C. F., & Rother, R. P. (2005) · Blood · doi:10.1182/blood-2005-02-0564 · Cited by 212
An Anti-inflammatory Function for the Complement Anaphylatoxin C5a-binding Protein, C5L2
Gerard, N. P., Lu, B., Liu, P., Craig, S., Fujiwara, Y., Okinaga, S., & Gerard, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500287200 · Cited by 201
Complement drives Th17 cell differentiation and triggers autoimmune arthritis
Hashimoto, M., Hirota, K., Yoshitomi, H., Maeda, S., Teradaira, S., Akizuki, S., Prieto-Martin, P., Nomura, T., Sakaguchi, N., Köhl, J., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092301 · Cited by 195
Wang, Y., Kristan, J., Hao, L., Lenkoski, C. S., Shen, Y., & Matis, L. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4340 · Cited by 192
Tschopp, J., Chonn, A., Hertig, S., & French, L. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.4.2159 · Cited by 190
Manthey, H. D., Woodruff, T. M., Taylor, S. M., & Monk, P. N. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.04.005 · Cited by 180
Self-citationLanger, H. F., Chung, K.-J., Orlova, V. V., Choi, E. Y., Kaul, S., Kruhlak, M. J., Alatsatianos, M., DeAngelis, R. A., Roche, P. A., Magotti, P., et al. (2010) · Blood · doi:10.1182/blood-2010-01-261503 · Cited by 176 · cited 2×
“…apoptosis in neurons (Mukherjee and Pasinetti, 2001), and can exert an anti-inflammatory effect in pancreatitis (Bhatia et al., 2001), act as a potent inhibitor of angiogenesis (Langer et al., 2010), and is involved in the early priming stages of liver regeneration (Strey et al., 2003).”
BackgroundThe Complement Factor C5a Contributes to Pathology in a Rat Model of Amyotrophic Lateral Sclerosis
Woodruff, T. M., Costantini, K. J., Crane, J. W., Atkin, J. D., Monk, P. N., Taylor, S. M., & Noakes, P. G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8727 · Cited by 165
Self-citationVergunst, C. E., Gerlag, D. M., Dinant, H., Schulz, L., Vinkenoog, M., Smeets, T. J. M., Sanders, M. E., Reedquist, K. A., & Tak, P. P. (2007) · Rheumatology · doi:10.1093/rheumatology/kem222 · Cited by 163
The Role of the Complement System and the Activation Fragment C5a in the Central Nervous System
Woodruff, T. M., Ager, R. R., Tenner, A. J., Noakes, P. G., & Taylor, S. M. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8085-y · Cited by 161
Self-citationProtection of innate immunity by C5aR antagonist in septic mice
Huber‐Lang, M. S., Riedeman, N. C., Sarma, J. V., Younkin, E. M., McGuire, S. R., Laudes, I. J., Lu, K. T., Guo, R., Neff, T. A., Padgaonkar, V. A., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0209com · Cited by 161
Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration
Woodruff, T. M., Crane, J. W., Proctor, L. M., Buller, K. M., Shek, A., Vos, K. J. D., Pollitt, S., Williams, H. M., Shiels, I. A., Monk, P. N., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5814com · Cited by 154
Self-citationThe SC5b-7 Complex: Formation, Isolation, Properties, and Subunit Composition
Podack, E. R., Kolb, W. P., & Müller‐Eberhard, H. J. (1977) · The Journal of Immunology · doi:10.4049/jimmunol.119.6.2024 · Cited by 152
Development of C5a receptor antagonists. Differential loss of functional responses.
Konteatis, Z. D., Siciliano, S. J., Riper, G. V., Molineaux, C. J., Pandya, S., Fischer, P. A., Rosen, H., Mumford, R. A., & Springer, M. S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.9.4200 · Cited by 151
The membrane attack complex of complement induces caspase activation and apoptosis
Nauta, A. J., Daha, M. R., Tijsma, O., van de Water, B., Tedesco, F., & Roos, A. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<783::aid-immu783>3.0.co;2-q · Cited by 148
Self-citationComplement Inhibitor Eculizumab in Atypical Hemolytic Uremic Syndrome
Mache, C. J., Acham‐Roschitz, B., Frémeaux‐Bacchi, V., Kirschfink, M., Zipfel, P. F., Rödl, S., Vester, U., & Ring, E. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01090209 · Cited by 148
aHUS caused by complement dysregulation: new therapies on the horizon
Waters, A. M., & Licht, C. P. B. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1556-4 · Cited by 143
The human complement fragment receptor, C5L2, is a recycling decoy receptor
Scola, A.-M., Johswich, K. O., Morgan, B. P., Klos, A., & Monk, P. N. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.11.001 · Cited by 140
The role of HMGB1 in the pathogenesis of rheumatic disease
Andersson, U., & Harris, H. E. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.11.003 · Cited by 137
Heller, T., Hennecke, M., Baumann, U., Gessner, J. E., zu Vilsendorf, A. M., Baensch, M., Boulay, F., Kola, A., Klos, A., Bautsch, W., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.985 · Cited by 136
Structure of and influence of a tick complement inhibitor on human complement component 5
Fredslund, F., Laursen, N. S., Roversi, P., Jenner, L. B., Oliveira, C. L. P., Pedersen, J. S., Nunn, M. A., Lea, S. M., DiScipio, R. G., Sottrup‐Jensen, L., et al. (2008) · Nature Immunology · doi:10.1038/ni.1625 · Cited by 134
Dmytrijuk, A., Robie‐Suh, K., Cohen, M. H., Rieves, D., Weiss, K., & Pazdur, R. (2008) · The Oncologist · doi:10.1634/theoncologist.2008-0086 · Cited by 134
Complement regulatory proteins in glomerular diseases
Nangaku, M. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00130.x · Cited by 133
Rosmarinic acid: A new inhibitor of complement C3-convertase with anti-inflammatory activity
Englberger, W., Hadding, U., Etschenberg, E., Graf, E. O., Leyck, S., Winkelmann, J., & Parnham, M. J. (1988) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(88)90026-4 · Cited by 125
Complement C5 Mediates Experimental Tubulointerstitial Fibrosis
Boor, P., Konieczny, A., Villa, L., Schult, A. L., Diaeresis]cher, E. B., Rong, S., Kunter, U., van Roeyen, C. R. C., Polakowski, T., Hawlisch, H., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121343 · Cited by 124
Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications
Laarman, A. J., Milder, F. J., van Strijp, J. A. G., & Rooijakkers, S. H. M. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0572-y · Cited by 120
Skokowa, J., Ali, S. R., Felda, O., Kumar, V. V., Konrad, S., Shushakova, N., Schmidt, R. E., Piekorz, R. P., Nürnberg, B., Spicher, K., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.3041 · Cited by 119
Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice
Kumar, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25536 · Cited by 118
Dendritic cell function in allostimulation is modulated by C5aR signaling
Peng, Q., Li, K., Wang, N., Li, Q., Asgari, E., Lu, B., Woodruff, T. M., Sacks, S. H., & Zhou, W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804186 · Cited by 116
Self-citationMukherjee, P., & Pasinetti, G. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00167.x · Cited by 111
Fabio Fischetti, I., & Tedesco, F. (2006) · Autoimmunity · doi:10.1080/08916930600739712 · Cited by 107
Self-citationC5 deficiency and C5a or C5aR blockade protects against cerebral malaria
Patel, S. N., Berghout, J., Lovegrove, F. E., Ayi, K., Conroy, A. L., Serghides, L., Min‐Oo, G., Gowda, D. C., Sarma, J. V., Rittirsch, D., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072248 · Cited by 105
The Devil in the Details: The Emerging Role of Anticitrulline Autoimmunity in Rheumatoid Arthritis
van Gaalen, F. A., Ioan‐Facsinay, A., Huizinga, T. W. J., & Toes, R. E. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5575 · Cited by 103
Strachan, A. J., Woodruff, T. M., Haaima, G., Fairlie, D. P., & Taylor, S. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6560 · Cited by 102
Self-citationIdentification of a Potent and Orally Active Non-peptide C5a Receptor Antagonist
Sumichika, H., Sakata, K., Sato, N., Takeshita, S., Ishibuchi, S., Nakamura, M., Kamahori, T., Ehara, S., Itoh, K., Ohtsuka, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209672200 · Cited by 99
A Critical Role for C5L2 in the Pathogenesis of Experimental Allergic Asthma
Zhang, X., Schmudde, I., Laumonnier, Y., Pandey, M. K., Clark, J. R., König, P., Gerard, N. P., Gerard, C. J., Wills-Karp, M. A., & Köhl, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000892 · Cited by 97
Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus
Laursen, N. S., Gordon, N., Hermans, S. J., Lorenz, N., Jackson, N. P., Wines, B. D., Spillner, E., Christensen, J. B., Jensen, M., Fredslund, F., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910565107 · Cited by 96
Arumugam, T. V., Shiels, I. A., Woodruff, T. M., Reid, R. C., Fairlie, D. P., & Taylor, S. M. (2002) · Journal of Surgical Research · doi:10.1006/jsre.2002.6369 · Cited by 96
Self-citationThe inhibitory effect of rosmarinic acid on complement involves the C5 convertase
Peake, P. W., Pussell, B. A., Martyn, P., et al. (1991) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(91)90036-7 · Cited by 92
Inhibition of Terminal Complement Complex Formation and Cell Lysis by Monoclonal Antibodies
Würzner, R., Schulze, M., Happe, L., Franzke, A., BIEBER, F. A., Oppermann, M., & Götze, O. (2017) · Complement and Inflammation · doi:10.1159/000463204 · Cited by 90
Ager, R. R., Fonseca, M. I., Chu, S., Sanderson, S. D., Taylor, S. M., Woodruff, T. M., & Tenner, A. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06595.x · Cited by 87
Self-citationPharmacological characterization of antagonists of the C5a receptor
Paczkowski, N. J., Finch, A. M., Whitmore, J. B., Short, A. J., Wong, A. K., Monk, P. N., Cain, S. A., Fairlie, D. P., & Taylor, S. M. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702938 · Cited by 87
Pexelizumab in ischemic heart disease: A systematic review and meta-analysis on 15,196 patients
Testa, L., van Gaal, W. J., Bhindi, R., Biondi‐Zoccai, G., Abbate, A., Agostoni, P., Porto, I., Andreotti, F., Crea, F., & BANNING, A. P. (2008) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.12.062 · Cited by 87
Gancz, D., & Fishelson, Z. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.05.009 · Cited by 87
Smith, P. K., Shernan, S. K., Chen, J. C., Carrier, M., Verrier, E. D., Adams, P. X., Todaro, T. G., Muhlbaier, L. H., & Levy, J. H. (2010) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2010.08.035 · Cited by 84
Hepburn, N. J., Williams, A. S., Nunn, M. A., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609858200 · Cited by 84
Dobrina, A., Pausa, M., Fabio Fischetti, I., Bulla, R., Vecile, E., Ferrero, E., Mantovani, A., & Tedesco, F. (2002) · Blood · doi:10.1182/blood.v99.1.185 · Cited by 82
Self-citationWong, A. K., Finch, A. M., Pierens, G. K., Craik, D. J., Taylor, S. M., & Fairlie, D. P. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9800651 · Cited by 82
Johansson, Å. C. M., Sundler, M., Kjellén, P., Johannesson, M., Cook, A. D., Lindqvist, A.-K., Nakken, B., Bolstad, A. I., Jonsson, R., Alarcón-Riquelme, M. E., et al. (2001) · European Journal of Immunology · Cited by 82
Substrate recognition by complement convertases revealed in the C5–cobra venom factor complex
Laursen, N. S., Andersen, K. R., Braren, I., Spillner, E., Sottrup‐Jensen, L., & Andersen, G. R. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.341 · Cited by 82
Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival
Lewis, A. G., Köhl, G., Ma, Q., Devarajan, P., & Köhl, J. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03678.x · Cited by 81
Drug evaluation: the C5a receptor antagonist PMX-53.
Köhl, J. (2006) · PubMed · Cited by 80
Complement-specific antibodies: Designing novel anti-inflammatories
Matis, L. A., & Rollins, S. A. (1995) · Nature Medicine · doi:10.1038/nm0895-839 · Cited by 80
Tsuboi, N., Ernandez, T., Li, X., Nishi, H., Culleré, X., Mekala, D. J., Hazen, M. M., Köhl, J., Lee, D. M., & Mayadas, T. N. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30141 · Cited by 78
Woodruff, T. M., Pollitt, S., Proctor, L. M., Stocks, S. Z., Manthey, H. D., Williams, H. M., Mahadevan, I. B., Shiels, I. A., & Taylor, S. M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.086835 · Cited by 78
Self-citationC5a Mutants Are Potent Antagonists of the C5a Receptor (CD88) and of C5L2
Otto, M., Hawlisch, H., Monk, P. N., Müller, M., Klos, A., Karp, C. L., & Köhl, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310078200 · Cited by 72
Zhang, X., Lewkowich, I. P., Köhl, G., Clark, J. R., Wills-Karp, M. A., & Köhl, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804276 · Cited by 68
Bhatia, M., Saluja, A. K., Singh, V. P., Frossard, J., Lee, H. S., Bhagat, L., Gerard, C. J., & Steer, M. L. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.5.g974 · Cited by 67
Syed, S. N., Konrad, S., Wiege, K., Nieswandt, B., Nimmerjahn, F., Schmidt, R. E., & Gessner, J. E. (2009) · European Journal of Immunology · doi:10.1002/eji.200939884 · Cited by 67
Lee, H., Zahra, D., Vogelzang, A., Newton, R. A., Thatcher, J., Quan, A., So, T., Zwirner, J., Köentgen, F., Padkjær, S. B., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1248 · Cited by 66
C5a Receptor Targeting in Neointima Formation After Arterial Injury in Atherosclerosis-Prone Mice
Shagdarsuren, E., Bidzhekov, K., Mause, S. F., Simsekyilmaz, S., Polakowski, T., Hawlisch, H., Gessner, J. E., Zernecke, A., & Weber, C. (2010) · Circulation · doi:10.1161/circulationaha.110.954370 · Cited by 65
The Role of the N-terminal Domain of the Complement Fragment Receptor C5L2 in Ligand Binding
Scola, A.-M., Higginbottom, A., Partridge, L. J., Reid, R. C., Woodruff, T. M., Taylor, S. M., Fairlie, D. P., & Monk, P. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609178200 · Cited by 62
Self-citationBossi, F., Rizzi, L., Bulla, R., et al. (2009) · Blood · doi:10.1182/blood-2008-03-146472 · Cited by 60
Identification and synthesis of a receptor binding site of human anaphylatoxin C5a
Kawai, M., Quincy, D. A., Lane, B. C., Mollison, K. W., Luly, J. R., & Carter, G. W. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00111a022 · Cited by 59
Fleming, S. D., Mastellos, D. C., Karpel‐Massler, G., Shea‐Donohue, T., Lambris, J. D., & Tsokos, G. C. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00160-8 · Cited by 58
Abe, K., LI, K., Sacks, S. H., & Sheerin, N. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02411.x · Cited by 55
Higginbottom, A., Cain, S. A., Woodruff, T. M., Proctor, L. M., Madala, P. K., Tyndall, J. D. A., Taylor, S. M., Fairlie, D. P., & Monk, P. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410797200 · Cited by 54
Self-citationTokodai, K., Goto, M., Inagaki, A., Nakanishi, W., Ogawa, N., Satoh, K., Kawagishi, N., Sekiguchi, S., Nilsson, B., Okada, N., et al. (2010) · Transplantation · doi:10.1097/tp.0b013e3181ffb9f5 · Cited by 51
Kagawa, T. F., O'Connell, M. R., Mouat, P., Paoli, M., O'Toole, P. W., & Cooney, J. C. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.12.074 · Cited by 50
Riley, R. D., Sato, H., Zhao, Z., Thourani, V. H., Jordan, J. E., Fernandez, A. X., Ma, X., Hite, D., Rigel, D. F., Pellas, T. C., et al. (2000) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2000.107281 · Cited by 45
Schnatbaum, K., Locardi, E., Scharn, D., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.07.036 · Cited by 45
Konrad, S., Ali, S. R., Wiege, K., Syed, S. N., Engling, L., Piekorz, R. P., Hirsch, E., Nürnberg, B., Schmidt, R. E., & Gessner, J. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804617200 · Cited by 44
Cleavage of the Human C5A Receptor by Protienases Derived from Porphyromonas Gingivalis
Jagels, M. A., Ember, J. A., Travis, J. W., et al. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0335-0_19 · Cited by 42
Pals, J. V. D., Koul, S., Andersson, P., Götberg, M., Ubachs, J. F. A., Kanski, M., Arheden, H., Olivecrona, G., Larsson, B., & Erlinge, D. (2010) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-10-45 · Cited by 42
Complement inhibition reduces injury in the type 2 diabetic heart following ischemia and reperfusion
Bonte, L. R. L., Davis‐Gorman, G., Stahl, G. L., & McDonagh, P. F. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00843.2007 · Cited by 39
Plant, D., Thomson, W., Lunt, M., Flynn, E., Martin, P., Eyre, S., Farragher, T. M., Bunn, D. K., Worthington, J., Symmons, D. P. M., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/keq032 · Cited by 39
Gao, L., Qiu, W., Wang, Y., et al. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03069.x · Cited by 38
Nandakumar, K. S., Jansson, Å., Xu, B., Rydell, N., Blom, A. M., & Holmdahl, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013511 · Cited by 36
Self-citationCorallini, F., Bossi, F., Gonelli, A., Tripodo, C., Castellino, G., Mollnes, T. E., Tedesco, F., Rizzi, L., Trotta, F., Zauli, G., et al. (2008) · Rheumatology · doi:10.1093/rheumatology/ken495 · Cited by 34
Self-citationFabio Fischetti, I., Durigutto, P., Macor, P., Marzari, R., Carretta, R., & Tedesco, F. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22492 · Cited by 33
Self-citationBrodbeck, R. M., Cortright, D. N., Kieltyka, A., Yu, J., Baltazar, C., Buck, M. E., Meade, R., Maynard, G. D., Thurkauf, A., Chien, D., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141572 · Cited by 30
Tegla, C., Cudrici, C. D., Rus, V., Ito, T., Vlaicu, S. I., Singh, A., & Rus, H. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.06.006 · Cited by 27
Synthesis and characterization of 5,6,7,8-tetrahydroquinoline C5a receptor antagonists
Barbay, J. K., Gong, Y., Buntinx, M., Li, J., Claes, C., Hornby, P. J., Lommen, G. V., Wauwe, J. V., & He, W. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.03.049 · Cited by 27
Li, Q., Nacion, K. M., Bu, H., & Lin, F. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081093 · Cited by 25
Lindqvist, A.-K., Johannesson, M., Johansson, Å. C. M., Nandakumar, K. S., Blom, A. M., & Holmdahl, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3952 · Cited by 24
Self-citationChen, Y., Zhang, J., Guo, G., Ruan, Z., Jiang, M., Wu, S., Guo, S. J., Fei, L., Tang, Y., Yang, C., et al. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.10.026 · Cited by 24
Morgan, M., Bulmer, A. C., Woodruff, T. M., Proctor, L. M., Williams, H. M., Stocks, S. Z., Pollitt, S., Taylor, S. M., & Shiels, I. A. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.01.009 · Cited by 19
Self-citationHennecke, M., Kola, A., Baensch, M., et al. (1997) · Gene · doi:10.1016/s0378-1119(96)00611-7 · Cited by 16
Characterization of the Murine IgG Fc Receptor III and IIB Gene Promoters
Konrad, S., Engling, L., Schmidt, R. E., & Gessner, J. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707937200 · Cited by 16
Complement factor 5a as a therapeutic target
Woodruff, T. M., Proctor, L. M., Strachan, A., et al. (2006) · Drugs of the Future · doi:10.1358/dof.2006.031.04.980656 · Cited by 8
Self-citation
Cited by
Overview of complement activation and regulation
Noris, M., & Remuzzi, G. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.001 · Cited by 864
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
Perico, L., Benigni, A., Casiraghi, F., Ng, L. F. P., Renia, L., & Remuzzi, G. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00357-4 · Cited by 607
Taming lupus-a new understanding of pathogenesis is leading to clinical advances
Liu, Z., & Davidson, A. (2012) · Nature Medicine · doi:10.1038/nm.2752 · Cited by 433
Therapeutic siRNA: State-of-the-Art and Future Perspectives
Friedrich, M., & Aigner, A. (2022) · BioDrugs · doi:10.1007/s40259-022-00549-3 · Cited by 396
Pittock, S. J., Lennon, V. A., McKeon, A., Mandrekar, J., Weinshenker, B. G., Lucchinetti, C. F., O'Toole, O., & Wingerchuk, D. M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70076-0 · Cited by 395
Metadata
- Authors
- Woodruff, T. M., Nandakumar, K. S., & Tedesco, F.
- Venue
- Molecular Immunology
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 48
- Issue
- 14
- Pages
- 1631-1642
- ISSN
- 0161-5890 (ISSN-L)
- OpenAlex
- W2113776905
- Cited by
- 289
- References
- 134
- FWCI
- 11.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.